Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.56B
• 1 day: 0.33%
• 5 days: 2.63%
• 1 month: 15.95%
• 3 months: 37.31%
• 6 months: 45.28%
• Year to date: -6.77%
• 1 year: -15.93%
• 5 years: 243.04%
• 10 years: 96.08%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437